Urodynamic effects of finasteride in the treatment of bladder outlet obstruction due to benign prostatic hyperplasia

Journal of Urology

Volumn 149, Issue 2, 1993, Pages 342-344

  Tammela, T L J ^a   Kontturi, M J ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

prostatic hypertrophy; stanolone; urodynamics

Indexed keywords

FINASTERIDE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER NECK STENOSIS; CLINICAL ARTICLE; DETRUSOR MUSCLE; DRUG EFFECT; DRUG EFFICACY; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RESIDUAL URINE; URINE FLOW RATE; URODYNAMICS; UROFLOWMETRY;

EID: 0027461812     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(17)36077-9     Document Type: Article

References (24)

1. Berry S.J. Coffey D.S. Walsh P.C. Ewing L.L. The development of human benign prostatic hyperplasia with age J. Urol. 132 1984 474
2. McNeal J.E. Origin and evolution of benign prostatic enlargement Invest. Urol. 15 1978 340
3. White J.W. The results of double castration in hypertrophy of the prostate Ann. Surg. 22 1895 1
4. Caine M. Perlberg S. Gordon R. The treatment of benign prostatic hypertrophy with flutamide (SCH 13521): a placebo-controlled study J. Urol. 114 1975 564
5. Bosch R.J.L.H. Griffiths D.J. Blom J.H.M. Schroeder F.H. Treatment of benign prostatic hyperplasia by androgen deprivation: effects on prostate size and urodynamic parameters J. Urol. 141 1989 68
6. Schroeder F.H. Westerhof M. Bosch R.J.L.H. Kurth K.H. Benign prostatic hyperplasia treated by castration or the LH-RH analogue buserelin: a report on 6 cases Eur. Urol. 12 1986 318
7. Peters C.A. Walsh P.C. The effect of nafarelin acetate, a luteinizing hormone-releasing hormone agonist, on benign prostatic hyperplasia New Engl. J. Med. 317 1987 599
8. Keane P.F. Timoney A.G. Kiely E. Williams G. Stamp G. Response of the benign hypertrophied prostate to treatment with an LHRH analogue Brit. J. Urol. 62 1988 163
9. Matzkin H. Chen J. Lewysohn O. Braf Z. Treatment of benign prostatic hypertrophy by a long-acting gonadotropin-releasing hormone analogue: 1-year experience J. Urol. 145 1991 309
10. Bruchovsky N. Wilson J.D. The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro J. Biol. Chem. 243 1968 2012
11. Wilkin R.P. Bruchovsky N. Rennie P.S. Comeau T. Stromal localization of testosterone 5-alpha reductase in normal, hyperplastic and carcinomatous prostates Proc. Amer. Ass. Cancer 20 1979 419
12. Stoner E. Gregg H. Otterbein J.J. Stein E. Lamkin G. Vlasses P.H. Danzeisen J. Tobert J.A. Administration of MK-906, a 4-azasteroid compound results in marked suppression of serum dihydrotestosterone in healthy men Clin. Res. 35 1987 402A abstract
13. Stoner E. Finasteride Study Group: The clinical effects of a 5a-reductase inhibitor, finasteride, on benign prostatic hyperplasia J. Urol. 147 1992 1298
14. Blaivas J.G. de la Rocha R.E. Impaired urinary flow rate: the distinction between bladder outlet obstruction and poor detrusor contractility Proceedings of the 15th annual meeting of the International Continence Society, London 1985 51
15. Abrams P. Blaivas J.G. Stanton S.L. Andersen J.T. The standardisation of terminology of lower urinary tract function. The International Continence Society Committee on Standardisation of Terminology Scand. J. Urol. Nephrol. 114 suppl. 1988 5
16. Terris M.K. Stamey T.A. Determination of prostate volume by transrectal ultrasound J. Urol. 145 1991 984
17. Boyarsky S. Jones G. Paulson D.F. Prout G.R. Jr. A new look at bladder neck obstruction by the Food and Drug Administration regulators: guide lines for investigation of benign prostatic hypertrophy Trans. Amer. Ass. Genito-Urin. Surg. 68 1977 29
18. Lytton B. Emery J.M. Harvard B.M. The incidence of benign prostatic obstruction J. Urol. 99 1968 639
19. Geller J. Albert J. The effect of aging on the prostate S.G. Korenman Endocrine Aspects of Aging 1982 Elsevier Biomedical New York 137
20. Abrams P.H. Griffiths D.J. The assessment of prostatic obstruction from urodynamic measurements and from residual urine Brit. J. Urol. 51 1979 129
21. Kirby R.S. Eardley I. Bryan J. Miller P. Christmas T. Liu S. A urodynamic study of the value of finasteride in the management of bladder outflow obstruction due to BPH J. Urol. 145 part 2 1991 266A
22. Krieg M. Bartsch W. Thomsen M. Voigt K.D. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate J. Steroid. Biochem. 19 1983 155
23. Bartsch G. Frick J. Rüegg L. Bucher M. Holliger O. Oberholzer M. Rohr H.P. Electron microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia J. Urol. 122 1979 481
24. Levine A.C. Kirschenbaum A. Kaplan P. Droller M.J. Gabrilove J.L. Serum prostate-antigen levels in patients with benign prostatic hypertrophy treated with leuprolide Urology 35 1989 10